Malta Country Drug Report 2019

Drug-related infectious diseases

In Malta, the National Infectious Disease Surveillance Unit in the Department of Health receives notifications of positive cases from virology departments and prisons. There were no reports of newly diagnosed cases of human immunodeficiency virus (HIV) infection linked to injecting drug use in 2017.

Prevalence of HIV and HCV antibodies among people who inject drugs in Malta (%)
  Region HCV HIV
Data from 2016/17 (HIV) and from 2017 (HCV).
National 44.54 0.0 - 1.2
Sub-national : :

Prevalence estimates of HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV) come from diagnostic tests among people who inject drugs seeking treatment at the outpatient treatment unit run by Sedqa, the Maltese government’s executive agency in the drugs field. In 2016, two clients out of 170 tested positive for HIV. In 2017, 53 out of 119 tested positive for hepatitis C antibodies and one out of 83 tested positive for hepatitis B antibodies.


Malta main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.